ACTA1 and pancreatic neoplasm: We previously showed that immune competent mice bearing syngeneic mT5-2D pancreatic tumors also exhibited decreased intratumoral fibrosis [21] when treated with proglumide, and analysis of these tumors did not demonstrate any decrease in immunoreactivity to α-SMA.